JPRN-UMIN000007742招募中未知
Examination for the effect of combination therapy with raloxifene and eldecalcitol in primary osteoporotic patients -Switch from alfacalcidol to eldecalcitol- - Effect of combination therapy with raloxifene and eldecalcitol for osteoporosis -Switch from alfacalcidol to eldecalcitol
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patients who are diagnosed as contraindication of raloxifene treatments 2) Patients who are diagnosed as contraindication of eldecalcitol treatments 3) Patients who have serum calcium levels of above 10.5mg/dL 4) Patients who have taken osteoporosis treatments other than raloxifene and alfacalcidol 5) Patients who are inappropriate for this study by physician
研究者
相似试验
已完成
4 期
Examination for the effect of combination therapy with Eldecalcitol and Alendronate in primary osteoporotic patientsOsteoporosisJPRN-UMIN000008191Showa University100
已完成
不适用
Examination for the effect of combination therapy with raloxifene and eldecalcitol in postmenopausal osteoporotic patientsOsteoporosisJPRN-UMIN000008440Kurume University, Medical Department70
已完成
不适用
Examination for the effect of combination therapy with alendronate and eldecalcitol in primary osteoporotic patients :A randomized active comparator study -Switch from alfacalcidol to eldecalcitolOsteoporosisJPRN-UMIN000006964Tokyo Women's Medical University Medical Center East120
招募中
不适用
Examination for the effect of combination therapy using SERM and Eldecalcitol for the patients with osteoporosisOsteoporosisJPRN-UMIN000006027Department of Medicine for Motor Organ, Juntendo University Graduate School of Medicine150
尚未招募
不适用
The study about the effect of combination therapy of active form of vitamin D and lanthanum carbonate for serum concentration of FGF23chronic kidney diseaseJPRN-UMIN000030503Fujita Health University100